Australia markets close in 1 hour 54 minutes

MedMen Enterprises Inc. (0JS.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
0.00940.0000 (0.00%)
At close: 12:05PM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 13.00M
Enterprise value 355.89M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.21
Price/book (mrq)0.12
Enterprise value/revenue 2.96
Enterprise value/EBITDA -2.97

Trading information

Stock price history

Beta (5Y monthly) 1.42
52-week change 3-7.84%
S&P500 52-week change 321.08%
52-week high 30.0360
52-week low 30.0069
50-day moving average 30.0094
200-day moving average 30.0122

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 51.38B
Implied shares outstanding 61.51B
Float 81.36B
% held by insiders 11.31%
% held by institutions 12.25%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:9.2623
Last split date 328 May 2018

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 25 June 2022
Most-recent quarter (mrq)25 Mar 2023

Profitability

Profit margin -112.21%
Operating margin (ttm)-34.78%

Management effectiveness

Return on assets (ttm)-6.28%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)120.12M
Revenue per share (ttm)0.09
Quarterly revenue growth (yoy)-22.80%
Gross profit (ttm)N/A
EBITDA -14.41M
Net income avi to common (ttm)-143.31M
Diluted EPS (ttm)-0.1000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)7.63M
Total cash per share (mrq)0.01
Total debt (mrq)379.18M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.19
Book value per share (mrq)0.09

Cash flow statement

Operating cash flow (ttm)-20.35M
Levered free cash flow (ttm)-60.32M